Latest Headlines

Latest Headlines

China's Kelun Pharma opens $50M Kazakhstan plant for intravenous oncology drugs

China's Kelun Pharmaceutical has just opened a $50 million production plant in Almaty (formerly Alma-Ata), just across the border in Kazakhstan. Kelun Kazpharm executives told China's state-run Xinhua news agency the plant is responsible for 70% of the Kazakhstan market for intravenous medicines.

Lee's Pharma affiliate licenses Tragara's TG02 oncology treatment for much of Asia

An affiliate of Hong Kong-listed Lee's Pharmaceutical Holdings has licensed the TG02 oncology treatment developed by California-based Tragara Pharmaceuticals, the companies said in a statement.

Boston Sci moves deeper into oncology with $70M+ purchase from CeloNova

Cardiovascular-focused Boston Scientific is moving deeper into oncology and expanding its vascular offerings with the purchase of the interventional radiology portfolio of CeloNova BioSciences. The deal with the San Antonio, TX-based startup involves a $70 million upfront payment with additional, undisclosed regulatory and sales milestones.

NEA backs cancer genome Dx startup Personal Genome in $21M+ Series A

Another startup is emphatically advancing into the fray to elicit and apply genomic data as a guide for cancer diagnoses and treatment. Personal Genome Diagnostics has raised a $21.4 million Series A round to expand its commercial genomic oncology testing service.

China's Innovent Biologics deepens pact with Eli Lilly on immuno-oncology

China's Innovent Biologics has deepened a pact with Eli Lilly by including immuno-oncology bispecific antibodies for Innovent in Greater China and for the Indianapolis-based firm outside of the country, setting a new benchmark in a white-hot area of collaboration deals.

Stealth startup Onkos gets Series A, partnership for next-gen bone cancer surgery

Onkos Surgical has secured a Series A financing and partnered with MicroPort Orthopedics. The financial details were undisclosed in the company's announcement, but an SEC filing reveals that Onkos recently secured the first $6.1 million of a financing that's expected to total $15.3 million.

Japan's Eisai to present papers on Lenvima clinical data at European Cancer Congress

Japan's Eisai said it will present a series of clinical results on Lenvima (lenvatinib) and Halaven (eribulin), among other papers, at the European Cancer Congress, as the company works to grow its key oncology business.

China plans public health push on cancer, wants to expand screening

China plans a public health campaign on cancer that over the next three years will see screening for early detection expanded by nearly one-third, spur new drug development and direct focus on prevention that covers smoking, China Daily reported.

Oncology trials in China may see pilot program for 60-day IND decision

Investigational new drug applications for oncology in China may see a 60-day deadline for a thumbs up, or down, placing the country on a path already followed by Singapore, Taiwan and South Korea for quick early-stage decisions.

BeiGene plans wider footprint in China with Suzhou development site

BeiGene is moving to Suzhou, in part, with plans to branch out from its capital city headquarters and develop a novel oncology drug operation that includes a cGMP manufacturing facility in Suzhou's BioBAY, the company said in a press release.